Basic Information
| LncRNA/CircRNA Name | NONHSAT134556.2 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | T cell,B cell | Survival | ||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | childhood acute lymphoblastic leukemia |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | blood samples |
| Expression Pattern | up-regulated |
| Function Description | RT-qPCR results indicated that the expression levels of the lncRNAs NONHSAT027612.2 and NONHSAT134556.2 were significantly elevated in the blood and bone marrow of patients with cALL compared with the controls. In conclusion, the lncRNAs NONHSAT027612.2 and NONHSAT134556.2 may serve important roles in the pathogenesis of cALL via regulating immune response-associated pathways. |
| Pubmed ID | 30675275 |
| Year | 2019 |
| Title | Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemia |
External Links
| Links for NONHSAT134556.2 | GenBank HGNC NONCODE |
| Links for childhood acute lymphoblastic leukemia | OMIM COSMIC |